Corruption endemic in medicine chain, according to WHO
‘Corruption in the pharmaceutical sector occurs throughout all stages of the medicine chain, from research and development to dispensing and promotion’.
‘A lack of transparency and accountability within the medicines chain can also contribute to unethical practices and corruption’.
Unethical practices such as bribery, falsification of evidence, and mismanagement of conflicts of interest are ‘common throughout the medicine chain.’
These statements are all contained in a fact sheet from the World Health Organisation. The medicine chain refers to each step involved in getting drugs into the hands of patients, including drug creation, regulation, management and consumption. The report suggests a number of other concerns, for example: Clinical trials may be conducted without proper regulatory approval, royalties may be collected through manipulation or disregard of the patent system, corruption can also occur during the drug inspection process, products may be registered with incorrect or insufficient information and drugs may be produced through substandard or counterfeit methods. (www.naturalnews.com; www.who.int 2010)
For another piece on falsified research in cancer Click Here.